APA (7th ed.) Citation

M, B., TL, B., AI, C., HM, L., M, H., S, L., . . . NG, S. (2022). Optimization of Human Mesenchymal Stem Cells for Rheumatoid Arthritis: Implications for Improved Therapeutic Outcomes. ACR open rheumatology, 4(2), 152. https://doi.org/10.1002/acr2.11356

Chicago Style (17th ed.) Citation

M, Breitman, Bonfield TL, Caplan AI, Lazarus HM, Haghiac M, LaSalvia S, Reese-Koc J, and Singer NG. "Optimization of Human Mesenchymal Stem Cells for Rheumatoid Arthritis: Implications for Improved Therapeutic Outcomes." ACR Open Rheumatology 4, no. 2 (2022): 152. https://doi.org/10.1002/acr2.11356.

MLA (9th ed.) Citation

M, Breitman, et al. "Optimization of Human Mesenchymal Stem Cells for Rheumatoid Arthritis: Implications for Improved Therapeutic Outcomes." ACR Open Rheumatology, vol. 4, no. 2, 2022, p. 152, https://doi.org/10.1002/acr2.11356.